Literature DB >> 31209795

Has the adipokine profile an influence on the catch-up growth type in small for gestational age infants?

A Léniz1,2, M P Portillo1,3,4, Alfredo Fernández-Quintela5,6,7, M T Macarulla1,3,4, A Sarasua-Miranda8, M Del Hoyo8, I Díez-López8.   

Abstract

Infants born small for gestational age (SGA) are at increased risk of perinatal morbidity, persistent short stature, and metabolic alterations in later life. Moreover, the post-natal growth pattern of SGA infants may be an important contributor to health outcomes later in life, which can be influenced by adipokines. The aims of this study were to compare plasma adipokine profiles (leptin, adiponectin, vaspin, chemerin, and nephroblastoma overexpressed (NOV/CCN3)) among SGA newborns aged 3 months, with low, normal, or high catch-up, to search for potential differences between males and females and to analyze the evolution of several adipokines in plasma from SGA newborns between 3 and 24 months. This prospective, longitudinal study was addressed in SGA Caucasian subjects at Hospital Universitario de Álava-Txagorritxu. We observed that infants with fast catch-up showed significantly lower birth weight than the other two groups. As far as adipokines are concerned, they could have an influence on catch-up type because differences among the three experimental groups were found. It may be proposed that health prognoses in infants with slow and fast catch-up are opposite, not only in adulthood but also during their first months. Finally, adipokine evolution patterns during the first 24 months of age differ, depending on the adipokine, and 24-month-old males show lower levels of leptin, adiponectin, and omentin than females.

Entities:  

Keywords:  Adiponectin; Catch-up; Chemerin; Leptin; NOV/CCN3; Omentin; SGA; Vaspin

Mesh:

Substances:

Year:  2019        PMID: 31209795     DOI: 10.1007/s13105-019-00684-6

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  51 in total

1.  The Association Between Serum Vaspin and Omentin-1 Levels in Obese Children with Metabolic Syndrome.

Authors:  Muammer Buyukinan; Muge Atar; Ummugulsum Can; Ozgur Pirgon; Asuman Guzelant; Isa Deniz
Journal:  Metab Syndr Relat Disord       Date:  2018-01-10       Impact factor: 1.894

Review 2.  Vaspin in obesity and diabetes: pathophysiological and clinical significance.

Authors:  Matthias Blüher
Journal:  Endocrine       Date:  2011-12-03       Impact factor: 3.633

Review 3.  Brain adipocytokine action and metabolic regulation.

Authors:  Rexford S Ahima; Yong Qi; Neel S Singhal; Malaka B Jackson; Philipp E Scherer
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

4.  Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus.

Authors:  Hala O El-Mesallamy; Dina H Kassem; Ebtehal El-Demerdash; Ashraf I Amin
Journal:  Metabolism       Date:  2010-06-01       Impact factor: 8.694

5.  Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population.

Authors:  Kiymet Bozaoglu; David Segal; Katherine A Shields; Nik Cummings; Joanne E Curran; Anthony G Comuzzie; Michael C Mahaney; David L Rainwater; John L VandeBerg; Jean W MacCluer; Greg Collier; John Blangero; Ken Walder; Jeremy B M Jowett
Journal:  J Clin Endocrinol Metab       Date:  2009-05-26       Impact factor: 5.958

Review 6.  Vaspin (serpinA12) in obesity, insulin resistance, and inflammation.

Authors:  John T Heiker
Journal:  J Pept Sci       Date:  2014-03-05       Impact factor: 1.905

7.  Preterm and term births of small for gestational age infants: a population-based study of risk factors among nulliparous women.

Authors:  B Clausson; S Cnattingius; O Axelsson
Journal:  Br J Obstet Gynaecol       Date:  1998-09

Review 8.  The glucoregulatory actions of leptin.

Authors:  Anna M D'souza; Ursula H Neumann; Maria M Glavas; Timothy J Kieffer
Journal:  Mol Metab       Date:  2017-05-04       Impact factor: 7.422

Review 9.  Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development.

Authors:  Xavier Escoté; Saioa Gómez-Zorita; Miguel López-Yoldi; Iñaki Milton-Laskibar; Alfredo Fernández-Quintela; J Alfredo Martínez; María J Moreno-Aliaga; María P Portillo
Journal:  Int J Mol Sci       Date:  2017-08-15       Impact factor: 5.923

Review 10.  Chemerin: a multifaceted adipokine involved in metabolic disorders.

Authors:  Gisela Helfer; Qing-Feng Wu
Journal:  J Endocrinol       Date:  2018-05-30       Impact factor: 4.286

View more
  4 in total

1.  Chemerin concentrations in infants born small for gestational age: correlations with triglycerides and parameters related to glucose homeostasis.

Authors:  Asier Léniz; Alfredo Fernández-Quintela; Marta Del Hoyo; Ignacio Díez-López; María P Portillo
Journal:  J Physiol Biochem       Date:  2020-06-16       Impact factor: 4.158

2.  Special Issue: 2019 Consortium for Trans-Pyrenean Investigations on Obesity and Diabetes.

Authors:  Fermin I Milagro; Christian Carpéné
Journal:  J Physiol Biochem       Date:  2021-01-22       Impact factor: 4.158

Review 3.  The Role of the Adipokines in the Most Common Gestational Complications.

Authors:  Paweł Gutaj; Rafał Sibiak; Maurycy Jankowski; Karina Awdi; Rut Bryl; Paul Mozdziak; Bartosz Kempisty; Ewa Wender-Ozegowska
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

Review 4.  Chemerin as Potential Biomarker in Pediatric Diseases: A PRISMA-Compliant Study.

Authors:  Katarzyna Zdanowicz; Anna Bobrus-Chociej; Dariusz Marek Lebensztejn
Journal:  Biomedicines       Date:  2022-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.